# Propranolol Adjuvant Treatment of Bladder Cancer

> **NCT04493489** · PHASE2 · UNKNOWN · sponsor: **Central South University** · enrollment: 242 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Propranolol Hydrochloride
- **DRUG:** BCG

## Key facts

- **NCT ID:** NCT04493489
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-06
- **Primary completion:** 2023-09-06
- **Final completion:** 2024-09-06
- **Target enrollment:** 242 (ESTIMATED)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493489, "Propranolol Adjuvant Treatment of Bladder Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04493489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*